Skip to main content
Clinical Trials/CTRI/2017/10/009973
CTRI/2017/10/009973CompletedPhase 3

A comparative study of recurrence rate and visual outcome after Vitrectomy for Epiretinal membrane combined ERM plus ILM peeling versus ERM peeling only

De Research and development Organisation0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Cases with macular ERM confirmed by Optical coherence tomography(OCT) with vision 6/12 or worse will be included in the study.

Exclusion Criteria

  • a)Active intra ocular inflammation
  • b)Coexisting Diabetic or hypertensive macular oedema
  • c)Coexisting tractional or rhegmatogenous retinal detachment
  • d)Cases with macular hole.

Investigators

Sponsor
De Research and development Organisation

Similar Trials